Canine Leishmaniosis, often referred to as CanL, is a parasitic disease caused by the protozoan parasite Leishmania. This disease primarily affects dogs but can also affect other mammals, including humans. In this blog, we will delve into the various aspects of Canine Leishmaniosis, including its etiology, causes, symptoms, transmission, consequences, prevention measures, diagnosis methods, and treatment.

VETIVD™, which has made major breakthroughs in the field of animal diagnosis and treatment, recently announced that after 12 months of rigorous clinical trials, the canine leishmania immunofluorescence detection reagent it developed has successfully passed clinical verification by the School of Veterinary Medicine at the University of Messina. This result will Provide strong support for canine leishmaniasis prevention and control efforts worldwide.

VETIVD™ is excited to announce that their self-developed feline pancreas-specific lipase fPL diagnostic reagent has been honored with accreditation from the Faculty of Veterinary Medicine of the University of Messina. The Faculty of Veterinary Medicine of the University of Messina is a prestigious institution with a wide influence and authority in the field of veterinary medicine. Their recognition of VETIVD's™ diagnostic reagents is further proof of the product's superior performance.